wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26824877-1E7B01EB-DA6E-4544-9830-16EDBF640FCC
Q26824877-1E7B01EB-DA6E-4544-9830-16EDBF640FCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824877-1E7B01EB-DA6E-4544-9830-16EDBF640FCC
Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
P2860
Q26824877-1E7B01EB-DA6E-4544-9830-16EDBF640FCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824877-1E7B01EB-DA6E-4544-9830-16EDBF640FCC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4244bc24c6c52e475c9cafa48224c13a268c270
P2860
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.